Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Progenics Pharmaceuticals Inc. PGNX

Healthcare Biotechnology
"Progenics Pharmaceuticals Inc is an oncology company focused on developing and commercializing targeted medicines and artificial intelligence to treat cancer. Its portfolio includes AZEDRA (to treat malignant and recurrent pheochromocytoma and paraganglioma); 1404 and PyL (imaging agents for prostate cancer); 1404 Index and PyL (analytical tools for analysis and indexing of images for prostate... see more

Recent & Breaking News (NDAQ:PGNX)

Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Globe Newswire June 20, 2013

Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock

Globe Newswire June 19, 2013

InvestorsGuru.com 44 Filtered Mid-Day Market Movers Recap

Investors Guru June 16, 2013

Salix and Progenics Announce FDA Advisory Committee to Review Relistor sNDA for Opioid-Induced Constipation in Patients with Chronic Pain

Business Wire June 11, 2013

Progenics Pharmaceuticals Presents PSMA-Related Data at SNMMI 2013

Globe Newswire June 10, 2013

Progenics Pharmaceuticals' Data From a Phase 1 Study of PSMA ADC Presented at ASCO 2013

Globe Newswire June 1, 2013

Progenics Pharmaceuticals to Present at Jefferies Global Healthcare Conference

Globe Newswire May 31, 2013

Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index

Globe Newswire May 17, 2013

Faruqi & Faruqi, LLP Launches An Investigation Against Progenics Pharmaceuticals, Inc. (PGNX) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors

Business Wire May 10, 2013

Progenics Pharmaceuticals Announces First Quarter 2013 Financial Results

Globe Newswire May 10, 2013

Progenics Pharmaceuticals to Host Conference Call to Review First Quarter 2013 Financial Results on May 10

Globe Newswire May 6, 2013

Progenics Pharmaceuticals to Present at Needham Healthcare Conference

Globe Newswire April 24, 2013

Prescription for Success: Commercialization Efforts, Acquisitions and Enhanced Patent Protection - Research Report on PAREXEL International, Ironwood Pharmaceuticals, Opko Health, Amarin Corporation, Progenics Pharmaceuticals

PR Newswire March 19, 2013

Apple Inc. Shares Rise After Galaxy Launch - Futures Indicate Lower Open as the Market Takes Back Some of its Gains

PR Newswire March 18, 2013

Free Research Reports on GRPN, PGNX, TWO and ZUMZ Issued by the Bedford Report

Marketwired March 18, 2013

Squawk Box Stocks Reports on: Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), Groupon, Inc. (NASDAQ: GRPN), Glu Mobile, Inc. (NASDAQ: GLUU), 3D Systems Corp. (NYSE: DDD)

Marketwired March 18, 2013

InvestorsGuru.com Filtered Mid-Day Market Movers Recap

Vivian Danielson March 17, 2013

Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2012 Financial Results

Troy Schwensen March 15, 2013

Progenics Pharmaceuticals to Host Conference Call to Review Fourth Quarter Financial Results on March 15

Troy Schwensen March 8, 2013

Progenics Pharmaceuticals' Novel Small Molecule Drugs Targeting PSMA Successfully Visualize Prostate Cancer

Troy Schwensen March 5, 2013